Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
2(22%)
Results Posted
0%(0 trials)
Terminated
1(11%)

Phase Distribution

Ph phase_4
1
11%
Ph not_applicable
2
22%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution3 total trials
Phase 4Post-market surveillance
1(33.3%)
N/ANon-phased studies
2(66.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

2

trials recruiting

Total Trials

9

all time

Status Distribution
Active(3)
Completed(2)
Terminated(1)
Other(3)

Detailed Status

unknown3
Completed2
Enrolling by invitation1
Recruiting1
Terminated1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
2
Success Rate
66.7%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (33.3%)
N/A2 (66.7%)

Trials by Status

enrolling_by_invitation111%
recruiting111%
unknown333%
completed222%
terminated111%
active_not_recruiting111%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
9